{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T21:25:11Z","timestamp":1782854711266,"version":"3.54.5"},"reference-count":54,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001906","name":"Washington Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001906","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.dmd.2025.100144","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T23:16:34Z","timestamp":1754954194000},"page":"100144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Curcumin enhances the oral bioavailability of testosterone by inhibiting its intestinal metabolism"],"prefix":"10.1016","volume":"53","author":[{"given":"Namrata","family":"Bachhav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7248-6714","authenticated-orcid":false,"given":"Dilip Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7907-3734","authenticated-orcid":false,"given":"Griffin","family":"Shaffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7419-435X","authenticated-orcid":false,"given":"John K.","family":"Amory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6987-4918","authenticated-orcid":false,"given":"Bhagwat","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.dmd.2025.100144_bib1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.21037\/tau.2016.11.16","article-title":"Testosterone deficiency in adults and corresponding treatment patterns across the globe","volume":"6","author":"Anaissie","year":"2017","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.dmd.2025.100144_bib2","series-title":"National Center for Biotechnology Information (US)","article-title":"Male hypogonadism","author":"Sizar","year":"2024"},{"issue":"3","key":"10.1016\/j.dmd.2025.100144_bib3","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.21037\/tau.2020.03.33","article-title":"Genetics of hypogonadotropic hypogonadism","volume":"10","author":"Millar","year":"2021","journal-title":"Transl Androl Urol"},{"issue":"7","key":"10.1016\/j.dmd.2025.100144_bib4","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.mayocp.2016.04.022","article-title":"Adult-onset hypogonadism","volume":"91","author":"Khera","year":"2016","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.dmd.2025.100144_bib5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11102-008-0111-9","article-title":"Male hypogonadism","volume":"11","author":"Isidori","year":"2008","journal-title":"Pituitary"},{"key":"10.1016\/j.dmd.2025.100144_bib6","first-page":"1","year":"2022"},{"key":"10.1016\/j.dmd.2025.100144_bib7","first-page":"379","article-title":"Electrical charge properties of connective tissue in the insect central nervous system, with regard to ionic homeostasis of the nerve cell environment","volume":"43","author":"Schofield","year":"1989","journal-title":"Symp Soc Exp Biol"},{"issue":"1-2","key":"10.1016\/j.dmd.2025.100144_bib8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5489\/cuaj.2416","article-title":"Hypogonadism: easy to define, hard to diagnose, and controversial to treat","volume":"9","author":"Sterling","year":"2015","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.dmd.2025.100144_bib9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2147\/DHPS.S383130","article-title":"Safety aspects and rational use of testosterone undecanoate in the treatment of testosterone deficiency: clinical insights","volume":"15","author":"Campbell","year":"2023","journal-title":"Drug Healthc Patient Saf"},{"issue":"1","key":"10.1016\/j.dmd.2025.100144_bib10","first-page":"32","article-title":"Exogenous testosterone replacement therapy versus raising endogenous testosterone levels: current and future prospects","volume":"2","author":"Khodamoradi","year":"2021","journal-title":"F S Rev"},{"issue":"8","key":"10.1016\/j.dmd.2025.100144_bib11","article-title":"Is oral testosterone the new frontier of testosterone replacement therapy?","volume":"14","author":"Ahmad","year":"2022","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.dmd.2025.100144_bib12","first-page":"133","article-title":"Testosterone replacement therapy: a narrative review with a focus on new oral formulations","volume":"18","author":"Bhat","year":"2022","journal-title":"Eur Endocrinol"},{"issue":"5","key":"10.1016\/j.dmd.2025.100144_bib13","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/nau.25094","article-title":"The efficacy, safety, and outcomes of testosterone use among transgender men patients: a review of the literature","volume":"42","author":"Mwamba","year":"2023","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"10.1016\/j.dmd.2025.100144_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/jendso\/bvaa161","article-title":"Testosterone use in adolescent males: current practice and unmet needs","volume":"5","author":"Vogiatzi","year":"2021","journal-title":"J Endocr Soc"},{"issue":"2","key":"10.1016\/j.dmd.2025.100144_bib16","doi-asserted-by":"crossref","first-page":"190","DOI":"10.2164\/jandrol.111.013169","article-title":"Reexamination of pharmacokinetics of oral testosterone undecanoate in hypogonadal men with a new self-emulsifying formulation","volume":"33","author":"Yin","year":"2012","journal-title":"J Androl"},{"issue":"3","key":"10.1016\/j.dmd.2025.100144_bib17","doi-asserted-by":"crossref","first-page":"130","DOI":"10.5534\/wjmh.2015.33.3.130","article-title":"Testosterone replacement therapy and cardiovascular risk: a review","volume":"33","author":"Corona","year":"2015","journal-title":"World J Mens Health"},{"key":"10.1016\/j.dmd.2025.100144_bib18","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bcp.2018.08.003","article-title":"Quantitative characterization of UDP-glucuronosyltransferase 2B17 in human liver and intestine and its role in testosterone first-pass metabolism","volume":"156","author":"Zhang","year":"2018","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.dmd.2025.100144_bib19","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/cpt.2907","article-title":"Intestinal metabolism of diclofenac by polymorphic UGT2B17 correlates with its highly variable pharmacokinetics and safety across populations","volume":"114","author":"Ahire","year":"2023","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.dmd.2025.100144_bib20","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/cpt.3055","article-title":"Comparative intra-subject analysis of gene expression and protein abundance of major and minor drug metabolizing enzymes in healthy human jejunum and liver","volume":"115","author":"Wenzel","year":"2024","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.dmd.2025.100144_bib21","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1124\/dmd.118.080952","article-title":"Hepatic abundance and activity of androgen- and drug-metabolizing enzyme UGT2B17 are associated with genotype, age, and sex","volume":"46","author":"Bhatt","year":"2018","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"10.1016\/j.dmd.2025.100144_bib22","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.gpb.2016.03.008","article-title":"Corrigendum to \u201cpharmacogenomics of drug metabolizing enzymes and transporters: relevance to precision medicine.\u201d","volume":"14","author":"Ahmed","year":"2016","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"10.1016\/j.dmd.2025.100144_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.01021","article-title":"Turmeric and its major compound curcumin on health: bioactive effects and safety profiles for food, pharmaceutical, biotechnological and medicinal applications","volume":"11","author":"Sharifi-Rad","year":"2020","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.dmd.2025.100144_bib24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3390\/antibiotics11020135","article-title":"Curcumin: biological activities and modern pharmaceutical forms","volume":"11","author":"Uro\u0161evi\u0107","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.dmd.2025.100144_bib25","first-page":"1","article-title":"Curcumin, Gut Microbiota, and Neuroprotection","volume":"11","author":"Meo","year":"2019","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.dmd.2025.100144_bib26","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3390\/microorganisms12040642","article-title":"The modulatory effects of curcumin on the gut microbiota: a potential strategy for disease treatment and health promotion","volume":"12","author":"Zhu","year":"2024","journal-title":"Microorganisms"},{"key":"10.1016\/j.dmd.2025.100144_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2022.820806","article-title":"A comprehensive review on the therapeutic potential of curcuma longa linn. in relation to its major active constituent curcumin","volume":"13","author":"Fuloria","year":"2022","journal-title":"Front Pharmacol"},{"issue":"33","key":"10.1016\/j.dmd.2025.100144_bib28","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.2217\/fon-2021-0575","article-title":"Relugolix, an oral gonadotropin-releasing hormone antagonist for the treatment of prostate cancer","volume":"17","author":"George","year":"2021","journal-title":"Future Oncol"},{"key":"10.1016\/j.dmd.2025.100144_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115867","article-title":"Effect of probenecid on blood levels and renal elimination of furosemide and endogenous compounds in rats: discovery of putative organic anion transporter biomarkers","volume":"218","author":"Thakur","year":"2023","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"10.1016\/j.dmd.2025.100144_bib30","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/cpt.1764","article-title":"Normalized testosterone glucuronide as a potential urinary biomarker for highly variable UGT2B17 in children 7\u201318 years","volume":"107","author":"Zhang","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.dmd.2025.100144_bib31","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/01.ju.0000169490.78443.59","article-title":"Hypogonadism and metabolic syndrome: implications for testosterone therapy","volume":"174","author":"Makhsida","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.dmd.2025.100144_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2023.1201313","article-title":"The complications of male hypogonadism: is it just a matter of low testosterone?","volume":"14","author":"Munari","year":"2023","journal-title":"Front Endocrinol"},{"issue":"9","key":"10.1016\/j.dmd.2025.100144_bib33","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.31919","article-title":"Early access to testosterone therapy in transgender and gender-diverse adults seeking masculinization","volume":"6","author":"Nolan","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.dmd.2025.100144_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/26895269.2022.2100644","article-title":"Standards of care for the health of transgender and gender diverse people, version 8","volume":"23","author":"Coleman","year":"2022","journal-title":"Int J Transgend Health"},{"issue":"10","key":"10.1016\/j.dmd.2025.100144_bib35","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3390\/foods6100092","article-title":"Curcumin: a review of its effects on human health","volume":"6","author":"Hewlings","year":"2017","journal-title":"Foods"},{"key":"10.1016\/j.dmd.2025.100144_bib36","first-page":"1","article-title":"Impacts of turmeric and its principal bioactive curcumin on human health: pharmaceutical, medicinal, and food applications: a comprehensive review","volume":"9","author":"El-Saadony","year":"2022","journal-title":"Front Nutr"},{"issue":"2","key":"10.1016\/j.dmd.2025.100144_bib37","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.amjmed.2022.09.026","article-title":"Liver injury associated with turmeric\u2014a growing problem: ten cases from the drug-induced liver injury network [DILIN]","volume":"136","author":"Halegoua-DeMarzio","year":"2023","journal-title":"Am J Med"},{"issue":"7","key":"10.1016\/j.dmd.2025.100144_bib38","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3390\/nu10070855","article-title":"Curcumin in liver diseases: a systematic review of the cellular mechanisms of oxidative stress and clinical perspective","volume":"10","author":"Farzaei","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.dmd.2025.100144_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu11092147","article-title":"Dietary curcumin: correlation between bioavailability and health potential","volume":"11","author":"Dei Cas","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.dmd.2025.100144_bib40","first-page":"70","article-title":"[Experience in organizing an office for functional diagnosis based in an urban dental polyclinic]","volume":"77","author":"Vagner","year":"1998","journal-title":"Stomatologiia (Mosk)"},{"issue":"6","key":"10.1016\/j.dmd.2025.100144_bib41","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3390\/molecules22060976","article-title":"Inhibitory effects of diclofenac on steroid glucuronidation in vivo do not affect hair-based doping tests for stanozolol","volume":"22","author":"Zach\u00e1r","year":"2017","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.dmd.2025.100144_bib42","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1021\/acs.jcim.3c01514","article-title":"Promiscuity and quantitative contribution of UGT2B17 in drug and steroid metabolism determined by experimental and computational approaches","volume":"64","author":"Ahire","year":"2024","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.dmd.2025.100144_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2013.00080","article-title":"Effects of dietary components on testosterone metabolism via UDP-glucuronosyltransferase","volume":"4","author":"Jenkinson","year":"2013","journal-title":"Front Endocrinol"},{"issue":"2","key":"10.1016\/j.dmd.2025.100144_bib44","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3109\/10717544.2014.918677","article-title":"Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin","volume":"23","author":"Ji","year":"2016","journal-title":"Drug Deliv"},{"issue":"9","key":"10.1016\/j.dmd.2025.100144_bib45","first-page":"1","article-title":"Nirmatrelvir combined with ritonavir for preventing and treating COVID-19","volume":"2022","author":"Reis","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.dmd.2025.100144_bib46","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1021\/acs.chemrestox.1c00028","article-title":"Inhibition of CYP3A7 DHEA-S oxidation by lopinavir and ritonavir: an alternative mechanism for adrenal impairment in HIV antiretroviral-treated neonates","volume":"34","author":"Kandel","year":"2021","journal-title":"Chem Res Toxicol"},{"issue":"8","key":"10.1016\/j.dmd.2025.100144_bib47","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1097\/QAD.0000000000002857","article-title":"Pharmacokinetics of darunavir and cobicistat in pregnant and postpartum women with HIV","volume":"35","author":"Momper","year":"2021","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.dmd.2025.100144_bib48","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/QAI.0000000000002856","article-title":"Pharmacokinetics of atazanavir boosted with cobicistat in pregnant and postpartum women with HIV","volume":"89","author":"Momper","year":"2022","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"10","key":"10.1016\/j.dmd.2025.100144_bib49","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1002\/psp4.13028","article-title":"Population pharmacokinetic analyses for belzutifan to inform dosing considerations and labeling","volume":"12","author":"Marathe","year":"2023","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"3","key":"10.1016\/j.dmd.2025.100144_bib50","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ajhg.2008.08.004","article-title":"Adaptive evolution of UGT2B17 copy-number variation","volume":"83","author":"Xue","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.dmd.2025.100144_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110574","article-title":"Drug-drug interaction potentials of tucatinib inhibition of human UDP-glucuronosyltransferases","volume":"381","author":"Lv","year":"2023","journal-title":"Chem Biol Interact"},{"issue":"8","key":"10.1016\/j.dmd.2025.100144_bib52","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1124\/dmd.108.020552","article-title":"Curcuminoids inhibit multiple human cytochromes P450, UDP-glucuronosyltransferase, and sulfotransferase enzymes, whereas piperine is a relatively selective CYP3A4 inhibitor","volume":"36","author":"Volak","year":"2008","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"10.1016\/j.dmd.2025.100144_bib53","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1124\/jpet.117.242107","article-title":"Race, gender, and genetic polymorphism contribute to variability in acetaminophen pharmacokinetics, metabolism, and protein-adduct concentrations in healthy African-American and European-American volunteers","volume":"362","author":"Court","year":"2017","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.dmd.2025.100144_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jpm12050720","article-title":"Common UGT1A6 variant alleles determine acetaminophen pharmacokinetics in man","volume":"12","author":"Cerezo-Arias","year":"2022","journal-title":"J Pers Med"},{"issue":"4","key":"10.1016\/j.dmd.2025.100144_bib55","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.euo.2023.11.024","article-title":"Testosterone recovery for relugolix versus leuprolide in men with advanced prostate cancer: results from the phase 3 HERO study","volume":"7","author":"Tutrone","year":"2024","journal-title":"Eur Urol Oncol"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625091536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625091536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T19:57:23Z","timestamp":1772827043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955625091536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":54,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0090955625091536"],"URL":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100144","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Curcumin enhances the oral bioavailability of testosterone by inhibiting its intestinal metabolism","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100144","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100144"}}